Development of Fluorescence-Based Assays for Key Viral Proteins in the SARS-CoV-2 Infection Process and Lifecycle

Mingzhenlong Deng1, Chuang Zhang1, Wanli Yan1

  • 1State Key Laboratory of Functions and Applications of Medicinal Plants, Engineering Research Center for the Development and Application of Ethnic Medicine and TCM (Ministry of Education), Guizhou Provincial Key Laboratory of Pharmaceutics, School of Pharmacy, Guizhou Medical University, Guiyang 550004, China.

Insights

This review highlights fluorescence-based assays for screening SARS-CoV-2 viral proteins like Spike, 3CLpro, and RdRp. These methods are crucial for discovering new COVID-19 antiviral drugs.

Area of Science:

  • Virology
  • Drug Discovery
  • Biochemistry

Background:

  • The COVID-19 pandemic, caused by SARS-CoV-2, presents a global health and economic challenge.
  • Five key viral proteins—Spike, 3CLpro, PLpro, RdRp, and Helicase—are critical for SARS-CoV-2 invasion and replication.
  • Targeting these proteins offers a promising strategy for developing novel antiviral therapeutics.

Purpose of the Study:

  • To review and elucidate the principles of fluorescence-based screening assays for five pivotal SARS-CoV-2 viral proteins.
  • To guide researchers in selecting and refining screening strategies for anti-SARS-CoV-2 drug discovery.
  • To facilitate the identification and development of lead compounds against SARS-CoV-2.

Main Methods:

  • Focuses on fluorescence-based assay methodologies.
  • Discusses screening approaches tailored for viral Spike, 3CLpro, PLpro, RdRp, and Helicase.
  • Emphasizes high-throughput screening techniques for efficiency.

Main Results:

  • Identifies fluorescence-based assays as predominant screening techniques.
  • Provides foundational principles and methodologies for these assays.
  • Highlights the importance of efficient screening for drug development.

Conclusions:

  • Fluorescence-based assays are vital for high-throughput screening of SARS-CoV-2 targets.
  • Effective screening methodologies accelerate the discovery of potential anti-COVID-19 drugs.
  • This review serves as a guide for optimizing antiviral drug development strategies.

Related Concept Videos

Viral Mutations00:36

Viral Mutations

A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material for adaptive...
Conjugated Proteins02:50

Conjugated Proteins

Simple proteins and protein complexes contain only amino acids. In contrast, many other proteins, called conjugated proteins, covalently bond with non-protein moieties.
Nucleoproteins are protein complexes that contain nucleic acids, categorized as deoxyribonucleoproteins (DNPs) or ribonucleoproteins (RNPs) respectively. The nucleosome is a typical example of a DNP where nuclear DNA is associated with histone proteins. The major antigen for the Covid-19 virus SARS-CoV is an RNP that is critical...
Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
Coronavirus01:29

Coronavirus

Coronaviruses, including the severe acute respiratory syndrome coronavirus (SARS-CoV), are enveloped viruses characterized by their single-stranded, positive-sense RNA genome and helical nucleocapsid structure. The hallmark of these viruses is their club-shaped spike (S) glycoproteins that protrude from the viral envelope, facilitating attachment to host cells. Typically, coronaviruses infect the upper respiratory tract, often causing mild or asymptomatic disease. However, certain strains like...